BackPerspective Therapeutics Overview

Perspective Therapeutics Net Income

Profitability analysis for ISR.

Quarterly Net Income

-$26.19M
44.08% YoY

As of Mar 2026

Annual Net Income (TTM)

-$111.13M
28.7% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...